Protamine nucleoprotein compound and application thereof

By developing fish sperm protein complex, the problem of lack of fish sperm protein complex particles in China has been solved, the erectile function and semen quality in men have been improved, and fertility has been improved, and an effective nutritional supplementation solution has been provided.

CN118976092APending Publication Date: 2024-11-19SHANDONG SHANDA HOSPITAL FOR REPRODIVE MEDICINE +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411000156.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-24
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

At present, there is a lack of research plans for fish sperm protein complex particles in China, which has led to the decline of male fertility and the difficulty in effectively solving the problems of erectile dysfunction.

Method used

Develop a fish sperm protein complex, including zinc-rich selenium-rich protein powder, fish sperm protein, zinc gluconate, selenium-rich malt powder, vitamin C, vitamin E, vitamin B1 and vitamin B2, and is prepared through specific preparation methods. Fish sperm powder, and is made into granule products through conventional processes, to improve male erectile function and semen quality.

Benefits of technology

This fish sperm protein complex can improve male erectile dysfunction, improve sperm concentration and vitality, reduce sperm malformation rate, meet the needs of men's fertility improvement, and have significant nutritional and health care effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118976092A_ABST
    Figure CN118976092A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of protamine nucleoprotein preparation methods, in particular to a protamine nucleoprotein compound and application thereof.The protamine nucleoprotein compound comprises, by weight, 20%-40% of zinc-rich selenium-rich protein powder, 1%-3% of protamine nucleoprotein, 1%-2% of zinc gluconate, 9%-11% of selenium-rich malt flour, 0.8%-1% of vitamin C, 0.17%-0.19% of vitamin E, 0.0014%-0.0016% of vitamin B1, 0.0014%-0.0016% of vitamin B2 and the balance auxiliary materials. The composition is rich in nutrient elements for improving male vigor, can be used as a supplementary medicine for improving male reproductive health, and is mainly applied to improving male erectile function, improving semen quality and improving semen vitality.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of a method for preparing a fish sperm nucleoprotein, and in particular to a fish sperm nucleoprotein complex and an application thereof. Background Art

[0002] Research results at home and abroad have shown that protamine is closely related to fertility. The DNA in protamine has the function of promoting cell activation, enhancing the body's resistance and strengthening reproductive function. The absence or reduction of protamine in male sperm reproductive cells may be related to male infertility. Human PⅡ protamine may also be closely related to fertility. It is precisely because of the synergistic effect of DNA and arginine in protamine that it has a significant effect in the auxiliary treatment of male infertility, and can treat male infertility caused by insufficient sperm secretion and sperm deficiency.

[0003] Numerous research results show that male semen quality is generally declining year by year due to the influence of social environment. Since the 1980s, WHO has lowered the normal values ​​of male sperm motility and sperm motility in the laboratory standards for routine semen examination several times, which also indirectly reflects the current situation of overall decline in male fertility. There is a huge demand gap in the field of male health and medicine. In recent years, with the in-depth understanding of fish sperm nucleoprotein, many studies have found that fish sperm nucleoprotein has the effects of improving male function, enhancing male fertility, inhibiting cancer cell proliferation, improving physical fitness and preventing muscle fatigue, preventing and improving ischemic lesions, and preventing skin aging, and has excellent application prospects.

[0004] Compared with traditional protamine, the nucleic acid components contained in protamine nucleoprotein may have better nutritional and health effects. A large number of studies have shown that dietary nucleotides affect immune regulation, help iron absorption in the intestine, and affect the desaturation and elongation of fatty acid synthesis. In vitro studies have confirmed that exogenous nucleotide supplementation can regulate cell apoptosis and proliferation processes.

[0005] Western countries and Japan have begun to develop and utilize fish testes on a large scale to obtain fish sperm nucleoprotein. Its downstream products include medicines, edible nutrients and cosmetics. However, there is currently no research program on fish sperm nucleoprotein complex particles in China. Based on this, a fish sperm nucleoprotein complex particle was developed. Summary of the invention

[0006] In view of the fact that there is currently no research plan for fish sperm nucleoprotein complex particles in the prior art, the present invention aims to provide a fish sperm nucleoprotein complex and its application; the fish sperm nucleoprotein complex can improve male erectile dysfunction and improve male semen quality including increasing sperm concentration, improving sperm motility and reducing sperm deformity rate. At the same time, the present invention prepares fish sperm nucleoprotein powder, and then prepares granular products through conventional processes, which is simple to prepare.

[0007] In a first aspect, the present invention provides a protamine nucleoprotein complex, comprising the following components in weight percentage: 20%-40% zinc-rich and selenium-rich protein powder, 1%-3% protamine nucleoprotein, 1%-2% zinc gluconate, 9%-11% selenium-rich malt powder, 0.8%-1% vitamin C, 0.17%-0.19% vitamin E, 0.0014%-0.0016% vitamin B1, 0.0014%-0.0016% vitamin B2, and the remainder being auxiliary materials.

[0008] Furthermore, the preparation method of protamine nucleoprotein comprises the following steps: (1) Collect testes of salmon at stage V, wash and clean to remove dirt; (2) After washing with water, the tissue is placed in a high-speed tissue crusher for crushing. NaCl solution is added to the crushed testicular tissue, homogenized, stirred, allowed to stand, and centrifuged. After discarding the supernatant, the centrifugation is repeated once. After discarding the supernatant again, the precipitate obtained is the protamine nucleoprotein coarse powder; (3) The protamine nucleoprotein crude powder obtained in step (2) is placed in ethanol for precipitation, and the precipitate is washed, centrifuged, and vacuum dried to obtain protamine nucleoprotein refined powder.

[0009] Furthermore, in step (1), after washing with water to remove dirt, the testicular tissue is repeatedly immersed in a 0.2 mol sodium citrate solution for two times, each time for 30 minutes. The immersed testicular tissue can be frozen and stored at -80°C, and thawed at a temperature of 25-30°C when used.

[0010] Furthermore, in step (2), 100 ml of 140 mM NaCl solution was added to every 100 g of testicular tissue, the homogenization time was 1 minute, stirring was performed in an ice bath, and after stirring for 20 minutes, the mixture was allowed to stand for 10 minutes; the centrifugal speed was 4000 rpm, and the centrifugal time was 10 min.

[0011] Furthermore, in step (3), the centrifugal speed is 4000 rpm, the centrifugal time is 10 min, and the vacuum drying temperature is 40°C.

[0012] In a second aspect, the present invention provides a use of a protamine nucleoprotein complex in the preparation of a drug for improving male erectile function.

[0013] Furthermore, improving male erectile function includes improving mild to moderate male erectile dysfunction.

[0014] In a third aspect, the present invention provides an application of a fish sperm nucleoprotein complex in the preparation of a functional drug for improving semen quality.

[0015] Furthermore, improving semen quality includes increasing sperm concentration, enhancing sperm motility and reducing sperm deformity rate.

[0016] The beneficial effects of the present invention are: (1) The present invention is rich in nutrients that improve male energy and can be used as a supplementary medicine to improve male reproductive health.

[0017] (2) The present invention can improve mild to moderate male erectile dysfunction, increase male testicular spermatogenesis, sperm concentration, and sperm motility.

[0018] (3) The present invention can meet the current needs of the majority of men to improve their health and enhance their fertility.

[0019] (4) The present invention can prepare fish sperm nucleoprotein powder, and then prepare granular products through conventional processes, which is simple to prepare. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, for ordinary technicians in this field, other drawings can be obtained based on these drawings without paying any creative work.

[0021] Figure 1 It is a proliferation bar graph of GC-1 and GC-2 cells in a CCK-8 test according to a specific embodiment of the present invention.

[0022] Figure 2 It is a filling diagram of the GC-1 cell scratch range according to a specific embodiment of the present invention.

[0023] Figure 3 It is a bar graph of GC-1 cell proliferation efficiency according to a specific embodiment of the present invention.

[0024] Figure 4 It is a bar graph showing the improvement of SOD enzyme activity units according to a specific embodiment of the present invention. DETAILED DESCRIPTION In order to enable those skilled in the art to better understand the technical solutions in the present invention, the technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work should fall within the scope of protection of the present invention.

[0025] Example 1 The present invention provides a method for preparing protamine nucleoprotein, comprising: (1) Collect testes of salmon at stage V, clean and sort to remove glands, fat, connective tissue, blood clots and other dirt attached to the testes; soak in 0.2 M sodium citrate solution twice, each time for 30 minutes; wash with water, and the testicular tissue can be frozen at -80℃ and thawed at 25~30℃ before use.

[0026] (2) After washing with water, place the testis in a high-speed tissue crusher and crush it. Add 100 mL of 140 mM NaCl solution to every 100 g of testis tissue, homogenize for 1 minute, stir in an ice bath for 20 minutes, and then let it stand for 10 minutes; then centrifuge the testis tissue homogenate at 4000 rpm for 10 minutes; discard the supernatant and repeat the centrifugation once. After discarding the supernatant again, the precipitate obtained is the coarse protamine nucleoprotein powder.

[0027] (3) Place the crude protamine nucleoprotein powder in 3 times the volume of 95% ethanol solution for precipitation for 2 hours, with a centrifugal speed of 4000 rpm and a centrifugal time of 10 min. Take the precipitate after centrifugation; Place the crude protamine nucleoprotein powder in 2 times the volume of isopropanol solution and soak it for 10 hours. Take the precipitate after centrifugation and vacuum dry it at 40°C to obtain protamine nucleoprotein powder.

[0028] Test Example 1 In vitro test cell verification The results were verified by in vitro culture of P2 mouse spermatogonia (GC-1, Wuhan Prosai Life Science Co., Ltd.) and mouse spermatocytes (GC-2, Wuhan Prosai Life Science Co., Ltd.).

[0029] CCK-8 test (1) Prepare GC-1 and GC-2 cell suspensions, count and inoculate into 96-well plates, with approximately 100 μl per well.

[0030] (2) The protamine nucleoprotein prepared in Example 1 was dissolved in DMSO (Nanjing Quanlong Biotechnology Co., Ltd.), and filtered through a 0.22 μm filter.

[0031] (3) The culture plate was placed in an incubator for pre-culture for a period of time (37°C, 5% CO2). After the cells adhered to the wall, the protamine nucleoprotein prepared in Example 1 was added to the cell culture system at a final concentration of 0.28 μg / mL to 28.57 μg / mL. The culture medium was replaced after 24 hours of culture.

[0032] (4) Add H2O2 at a final concentration of 400 μM and culture for 24 hours.

[0033] (5) Add 10 μl of CCK-8 solution to each well.

[0034] (6) Place the culture plate in an incubator and incubate for 1 hour.

[0035] like Figure 1It can be seen from the CCK-8 test that protamine nucleoprotein can promote the proliferation of GC-1 and GC-2 cells in the final concentration range of 0.28~28.57μg / mL. The higher the concentration, the greater the proliferation activity of GC-1 and GC-2 cells.

[0036] Test Example 2 Scratch Test (1) Pretreatment with protamine nucleoprotein in Example 1: add protamine nucleoprotein in Example 1 to GC-1 at a final concentration of 2 μg / mL to 40 μg / mL, and replace the culture medium after culturing for 24 hours.

[0037] (2) Plating: GC-1 cells pretreated with protamine nucleoprotein in Example 1 were inoculated into 6-well culture plates at a density such that the fusion rate was 70-80% after overnight culture, and the total amount of culture medium per well was 2 mL.

[0038] (3) Scratch after overnight: The next day, use a 200 μL pipette tip and a ruler to scratch through the middle of the dish.

[0039] (4) Washing: Rinse the cells three times with PBS, remove the scratched cells, and add culture medium.

[0040] (5) Photography: Under a 4x microscope, take samples and take photos at 0, 6, 12, and 24 hours.

[0041] (6) Image J software was used to assist in calculating the mean scratch area.

[0042] like Figure 2 As can be seen in the upper middle figure, after the protamine nucleoprotein was exposed to the final concentration range of 2-40 μg / mL for 24 h, the scratch area was obviously filled; Figure 2 As can be seen in the lower middle figure, after adding 0.4 mM hydrogen peroxide and then protamine nucleoprotein, the scratch range was obviously filled.

[0043] Experimental Example 3 Mechanism Exploration GC-1 Cell Total SOD Activity Detection (1) Cell preparation: Add 100-200 μl of SOD sample preparation solution per 1 million cells, pipette appropriately to fully lyse the cells. Centrifuge at about 12,000 g at 4°C for 3-5 minutes, and take the supernatant as the sample to be tested.

[0044] (2) Kit preparation: a. Preparation of WST-8 / enzyme working solution: Prepare an appropriate amount of WST-8 / enzyme working solution according to the volume of 160μl per reaction, and evenly mix 151μl SOD detection buffer solution, 8μl WST-8 and 1μl enzyme solution to prepare 160μl WST-8 / enzyme working solution.

[0045] b. Preparation of reaction start working solution: Dissolve the reaction start solution (40X) and mix well. Dilute it according to the ratio of adding 39μl SOD detection buffer to every 1μl reaction start solution (40X). Mix well to obtain the reaction start working solution.

[0046] c. Preparation of SOD standard: Dilute the SOD standard with SOD sample preparation solution to the following concentration series: 100U / ml, 50U / ml, 20U / ml, 10U / ml, 5U / ml, 2U / ml, 1U / ml.

[0047] (3) Sample determination: a. Add the reaction starter solution and mix thoroughly.

[0048] b. Incubate at 37°C for 30 minutes.

[0049] c. Measure the absorbance at 450 nm.

[0050] Figure 3 In the figure, Y1-Y5 represent experimental group 1 to experimental group 5, respectively; H represents the hydrogen peroxide control group, and YH1-YH5 represent hydrogen peroxide experimental group 1 to hydrogen peroxide experimental group 5, respectively.

[0051] like Figure 3 It can be seen that protamine nucleoprotein can improve the proliferation efficiency of GC-1 cells when it acts in the final concentration range of 2~40μg / mL for 24h; the cell proliferation efficiency increases compensatorily after adding 0.4mM hydrogen peroxide; after further adding protamine nucleoprotein (final concentration 5~40μg / mL), the cell proliferation efficiency is further improved compared with the addition of protamine nucleoprotein alone.

[0052] Test Example 4 SOD enzyme activity calculation test SOD enzyme activity units in the sample to be tested = SOD enzyme activity units in the detection system = inhibition percentage / (1-inhibition percentage) units.

[0053] Figure 4 In the table, NC represents the control group, Y1-Y5 represent experimental groups 1-5, respectively; H represents the hydrogen peroxide control group, and YH1-YH5 represent hydrogen peroxide experimental groups 1-5, respectively.

[0054] like Figure 4 It can be seen that protamine nuclear protein can increase the SOD activity units of GC-1 cells in the final concentration range of 1.2~5μg / mL; the SOD activity units increase compensatorily after adding 0.4mM hydrogen peroxide; after further adding protamine nuclear protein (final concentration 1.2~20μg / mL), the SOD activity units are further increased.

[0055] Example 2 The invention provides a protamine nucleoprotein complex, comprising 30 g of zinc-rich and selenium-rich protein powder, 2 g of protamine nucleoprotein, 1.5 g of zinc gluconate, 10 g of selenium-rich malt powder, 0.9 g of vitamin C, 0.18 g of vitamin E, 15 mg of vitamin B1, 15 mg of vitamin B2 and 55.39 g of auxiliary materials. The granules are prepared by conventional processes and are packaged into 10 independent bags, each of which has a net weight of 10 g.

[0056] The protamine nucleoprotein complex particles in Example 2 were used for clinical verification, specifically: 1. The inclusion criteria for ED volunteers are as follows: (1) Males aged 20-60 years old; (2) A history of ED for at least 6 months; (3) IIEF-5 score 7-21; (4) No other ED treatment was taken concurrently in the past 6 months.

[0057] 2. The inclusion criteria for volunteers with oligospermia / asthenozoospermia are as follows: (1) Males aged 25-45 years; (2) The patient has undergone two or more semen examinations at a regular medical institution, indicating oligoasthenozoospermia and sperm concentration > 5×10 6 / mL; (3) No other treatments to improve fertility were taken in the past 6 months; (4) Excluding idiopathic azoospermia caused by trauma, inflammation, genetics, etc.

[0058] 3. The volunteer exclusion criteria are as follows: (1) Abnormal development, trauma or deformity of genitalia; (2) having a history of mental illness or concurrent use of psychotropic drugs; (3) Patients with severe cardiovascular and cerebrovascular diseases or liver and kidney dysfunction; (4) Those who are allergic to the components of protamine nucleoprotein complex.

[0059] 4. Grouping, treatment plan and efficacy evaluation indicators From December 2020 to April 2024, 30 male ED volunteers were enrolled and divided into the protamine nucleoprotein complex group (group A), protamine complex group (group B) and placebo group (group C) according to the random number table; 30 volunteers with oligospermia were enrolled and divided into the protamine nucleoprotein complex group (group D), protamine complex group (group E) and placebo group (group F) according to the random number table; 30 volunteers with asthenozoospermia were enrolled and divided into the protamine nucleoprotein complex group (group G), protamine complex group (group H) and placebo group (group I) according to the random number table. The protamine complex group was different from the protamine nucleoprotein complex group in that the protamine nucleoprotein in the protamine nucleoprotein complex used by the volunteers was replaced with an equal amount of protamine. The general information of all volunteers was collected, and all volunteers were fully informed and signed informed consent before participating in the treatment. The volunteers in groups A to C completed the IIEF-5 (International Index of Erectile Function) scale before medication, and the volunteers in groups D to I underwent semen evaluation according to the 6th edition of the WHO Laboratory Semen Examination Manual.

[0060] The volunteers were orally administered 10 g of the fish sperm nucleoprotein complex granules in Example 2, once a day. The medication was continued for 2 months, and the volunteers in Group A to Group C were re-examined at 1 month and 2 months of medication, and the volunteers in Groups A to C were required to complete the IIEF-5 scale. The volunteers in Groups D to I underwent semen quality assessment.

[0061] The IIEF-5 scores and changes in semen parameters before and after treatment were used as efficacy evaluation indicators.

[0062] 5. Statistical methods SPSS 24.0 was used to analyze the data. The AD test (Anderson-Darling test) was used for normality test; mean ± standard deviation (mean ± SD) was used to describe normally distributed quantitative data, and median was used to describe non-normally distributed quantitative data. The differences in indicators before and after treatment between the two groups were evaluated using paired t-tests, and the differences in indicators between multiple groups were evaluated using ANOVA tests; P ≤ 0.05 was used as the statistical difference standard.

[0063] 6. Results The average age of volunteers in each group was roughly the same, with no significant difference between groups, indicating that the homogeneity of the participants was good (Table 1) Table 1 Average age of volunteers in each group (years)

[0064] After one month of regular medication, the group using fish sperm nucleoprotein complex showed significant improvements in erectile function, sperm concentration and sperm forward motility rate compared with the corresponding placebo group.

[0065] Specifically: The baseline and average IIEF-5 scores of group A were 12.2±3.39. After using protamine nucleoprotein complex for 1 month, the average IIEF-5 score was 15.5±3.27. After using protamine nucleoprotein complex for 2 months, the average score was 15.8±3.22. The IIEF-5 scores during the medication period were significantly improved compared with the baseline level (P values ​​were all <0.01).

[0066] The IIEF-5 scores of group B at baseline, one month, and two months were 12.6±2.80, 13.0±2.54, and 14.1±2.77, respectively. There was no significant change in the scores compared with the baseline level after one month of medication (P value 0.309), and there was a significant improvement in the IIEF-5 scores after two months of medication (P value 0.026).

[0067] The IIEF-5 scores of group C at baseline, one month, and two months were 14.6±2.84, 14.2±2.86, and 14.7±2.71, respectively. There was no significant change in the scores compared with the baseline levels during the medication period (P values ​​were 0.269 and 0.758, respectively), indicating that protamine nucleoprotein complex can improve mild to moderate male erectile dysfunction, and its therapeutic effect is better than that of protamine complex, and the onset of effect is earlier than that of protamine complex (Table 2).

[0068] Table 2 Changes in IIEF-5 scores during the baseline medication period in the three groups A, B, and C compared with the baseline level

[0069] * P <0.05, considered statistically significant In terms of improving oligospermia, the baseline average sperm concentration of group D was 10.2±3.64 (million / ml), the average sperm concentration after 1 month of using protamine nucleoprotein complex was 13.3±3.72 (million / ml), and the average sperm concentration after 2 months of use was 12.2±3.65 (million / ml). The average sperm concentration during the medication period was significantly improved compared with the baseline level (P values ​​were all <0.01); the baseline average sperm concentration of group E was 10.3±2.85 (million / ml), the average sperm concentration after 1 month of using protamine complex was 11.4±3.06 (million / ml), and the average sperm concentration after 2 months of use was 1 2.2±2.80 (million / ml), the average sperm concentration at the two follow-up time points during the medication period was significantly increased compared with the baseline level (P values ​​were 0.013 and <0.01, respectively); the average sperm concentrations at baseline, 1 month and 2 months in group F were 10.2±2.58 (million / ml), 10.8±3.13 (million / ml), and 10.9±2.80 (million / ml), respectively, and there was no significant change in the average sperm concentration during the medication period compared with the baseline level (P values ​​were 0.164 and 0.200, respectively), indicating that the protamine nucleoprotein complex and protamine complex can enhance male testicular spermatogenesis and sperm concentration (Table 3).

[0070] Table 3 Average sperm concentration (million / mL) at both follow-up time points improved compared with baseline levels

[0071] * P <0.05, considered statistically significant In terms of improving asthenozoospermia, the baseline average forward sperm rate of group G was 21.0±6.99%, and the average forward motility rate was 23.8±7.68% after 1 month of using the fish sperm nucleoprotein complex, and the average forward motility rate was 23.7±6.75% after 2 months of use. The average forward motility rate during the medication period was significantly improved compared with the baseline level (all P values ​​< 0.01); the baseline average forward sperm rate of group H was 15.9±6.62%, and the average forward motility rate was 18.2±7.78% after 1 month of using the fish sperm nucleoprotein complex, which was significantly improved compared with the baseline level (all P values ​​< 0.01). After 2 months of use, the average forward motility rate was 18.1±7.36%, and the average forward motility rate during the medication period was significantly increased compared with the baseline level (P values ​​were <0.01 and 0.01, respectively). The average forward motility rates at baseline, 1 month and 2 months in Group I were 18.0±8.56%, 18.7±8.43% and 18.8±9.52%, respectively. There was no significant change in the average forward motility rate during the medication period compared with the baseline level (P values ​​were 0.119 and 0.224, respectively), indicating that the fish sperm nucleoprotein complex can enhance sperm motility (Table 4).

[0072] Table 4 Average forward movement rate (%) during medication period was improved compared with the baseline level

[0073] * P<0.05, considered statistically significant The present invention provides two typical medical cases: Medical Case 1 Gender: Male Age: 34 Chief complaint: No contraception and no childbearing for more than 1 year after marriage Current medical history: regular sexual life, 3 times / week on average. Erection and ejaculation are both OK. Semen routine examination at an external hospital showed: low sperm concentration, 10.2 million / mL; low motility, PR22.1%; high deformity rate, 98.2% abnormal sperm rate. Regular diet and bowel movements.

[0074] Past medical history: denied family history of genetic diseases, denied history of mumps / orchitis, denied history of testicular trauma, post-circumcision, denied drug and food allergies, no special hobbies of smoking and drinking, denied history of infectious diseases, denied combined medication.

[0075] Physical examination by specialist: The external genitalia developed normally, with no signs of trauma. The penis body was palpated without any hard masses. The testicles on both sides were about 15 mL, with a good texture. The epididymis was palpated without any nodules or masses, and the vas deferens on both sides were palpable.

[0076] The patient was seen in the outpatient clinic, and the reexamination of semen showed sperm concentration of 11.1 million / mL; PR19.7%; abnormal sperm rate 97.6%, and no abnormalities were found in the six sex hormone tests. Combined with the chief complaint, current medical history and laboratory test results, the patient was diagnosed with primary infertility and oligoasthenoteratozoospermia.

[0077] The patient took 10 g of the protamine nucleoprotein complex granules in Example 2 according to the doctor's advice, once a day, and was reviewed after one month and two months of medication.

[0078] The patient was re-examined one month after taking the medication and the semen was re-examined. The laboratory reported that the sperm concentration was 13.2 million / mL; PR was 24.6%; and the abnormal sperm rate was 96.5%.

[0079] The patient was re-examined two months after taking the medication and the semen was re-examined. The laboratory reported that the sperm concentration was 17.6 million / mL; PR was 31.1%; and the abnormal sperm rate was 94.3%.

[0080] Comparing the situation before and after medication, the patient's semen quality has improved to normal levels two months after treatment, proving that regular use of fish sperm nucleoprotein complex granules is effective in improving male semen quality.

[0081] Medical Case 2 Gender: Male Age: 39 Chief complaint: Unsatisfactory erection for 6 months Current medical history: The patient had unsatisfactory erection hardness during sexual intercourse six months ago without obvious cause, normal libido, EHS grade III, can complete insertion and ejaculation. Occasionally had morning erection, complained that masturbation and morning erection hardness were similar to sexual hardness. No drug treatment was performed, and the diet and bowel movements were regular recently.

[0082] Past medical history: denied family history of genetic diseases, denied history of penile and testicular trauma, denied drug and food allergies, no special hobbies of smoking and drinking, denied history of infectious diseases, and no recent concomitant medication.

[0083] Physical examination by specialist: The external genitalia developed normally, with no signs of trauma. The penis body was palpated without any hard masses. The testicles on both sides were about 12 mL, with a good texture. The epididymis was palpated without any nodules or masses, and the vas deferens on both sides were palpable.

[0084] The patient was seen in the outpatient clinic, and the IIEF-5 score was 14. The six sex hormone tests were normal. Combining the chief complaint, current medical history and IIEF scale results, the patient was diagnosed with erectile dysfunction.

[0085] The patient took 10 g of the protamine nucleoprotein complex granules in Example 2 once a day according to the doctor's advice. The patient was reexamined after one month, two months and three months of medication.

[0086] The re-evaluation of IIEF-5 was 17 points after one month of medication; the re-evaluation of IIEF-5 was 20 points after two months of medication; and the re-evaluation of IIEF-5 was 22 points after three months of medication.

[0087] Comparing the conditions before and after medication, the patient's IIEF-5 score improved to a normal level after three months of treatment, confirming that regular use of the protamine nucleoprotein complex granules in Example 2 is effective in improving male erectile function.

[0088] Although the present invention has been described in detail by referring to the accompanying drawings and in combination with the preferred embodiments, the present invention is not limited thereto. Without departing from the spirit and essence of the present invention, a person skilled in the art may make various equivalent modifications or substitutions to the embodiments of the present invention, and these modifications or substitutions shall be within the scope of the present invention. Any person skilled in the art who is familiar with the present technical field can easily think of changes or substitutions within the technical scope disclosed by the present invention, and they shall be within the scope of protection of the present invention.

Claims

1. A protamine nucleoprotein complex, characterized in that: The invention comprises the following components in percentage by weight: 20%-40% zinc-rich and selenium-rich protein powder, 1%-3% protamine nucleoprotein, 1%-2% zinc gluconate, 9%-11% selenium-rich malt powder, 0.8%-1% vitamin C, 0.17%-0.19% vitamin E, 0.0014%-0.0016% vitamin B1, 0.0014%-0.0016% vitamin B2, and the remainder are auxiliary materials.

2. The protamine nucleoprotein complex according to claim 1, characterized in that: The auxiliary materials include dextrin, microcrystalline cellulose, soluble starch and stearin in a weight ratio of 80:40:40:40:

1.

3. The protamine nucleoprotein complex according to claim 1, characterized in that: The preparation method of protamine nucleoprotein comprises the following steps: (1) Collect testes of salmon at stage V, wash and clean to remove dirt; (2) After washing with water, the tissue is placed in a high-speed tissue crusher for crushing. NaCl solution is added to the crushed testicular tissue, homogenized, stirred, allowed to stand, and centrifuged. After discarding the supernatant, the centrifugation is repeated once. After discarding the supernatant again, the precipitate obtained is the protamine nucleoprotein coarse powder; (3) The protamine nucleoprotein crude powder obtained in step (2) is placed in ethanol for precipitation, and the precipitate is washed, centrifuged, and vacuum dried to obtain protamine nucleoprotein refined powder.

4. A protamine nucleoprotein complex according to claim 3, characterized in that: In step (1), after washing with water to remove dirt, the testicular tissue is repeatedly immersed in a 0.2 mol sodium citrate solution for 2 times, each time for 30 minutes. The immersed testicular tissue is frozen and stored at -80°C, and thawed at a temperature of 25-30°C when used.

5. The protamine nucleoprotein complex according to claim 3, characterized in that: In step (2), 100 ml of 140 mM NaCl solution was added to every 100 g of testicular tissue, the homogenization time was 1 minute, stirring was performed in an ice bath, and after stirring for 20 minutes, the mixture was allowed to stand for 10 minutes; the centrifugal speed was 4000 rpm, and the centrifugal time was 10 min.

6. The protamine nucleoprotein complex according to claim 3, characterized in that: In step (3), the centrifugal speed is 4000 rpm, the centrifugal time is 10 min, and the vacuum drying temperature is 40°C.

7. Use of the protamine nucleoprotein complex according to claim 1 in the preparation of a drug for improving male erectile function.

8. The use according to claim 7, characterized in that Improving male erectile function includes improving mild to moderate male erectile dysfunction.

9. Use of the fish sperm nucleoprotein complex according to claim 1 in the preparation of a functional drug for improving semen quality.

10. The use according to claim 9, characterized in that Improving semen quality includes increasing sperm concentration, enhancing sperm motility and reducing sperm deformity rate.